Dr. Melia’s clinical research interests include Nocardia infections, Lyme disease, and HCV. He also maintains an active research interest in medical education and is developing a curriculum to improve the quality of teaching delivered by residents and fellows to medical students and interns.
Clinical Trial Keywords
Hepatitis C Virus
Co-Investigator. A Staged Phase I/II Study, to Assess Safety, Efficacy and Immunogenicity of a New Hepatitis C Prophylactic Vaccine Based on Sequential Use of AdCh3NSmut1 and MVA-NSmut
Dooley KE, Bliven-Sizemore EE, Weiner M, Lu Y, Nuermberger EL, Hubbard WC, Fuchs EJ, Melia MT, Burman WJ, Dorman SE. “Safety and Pharmacokinetics of Escalating Daily Doses of the Antituberculosis Drug Rifapentine in Healthy Volunteers.” Clin Pharmacol Ther. 2012;91(5):881-8. PMID 22472995.5.
Barclay SS, Melia MT, Auwaerter PG. “Misdiagnosis of late-onset Lyme arthritis by inappropriate use of Borrelia burgdorferi immunoblot testing with synovial fluid.” Clin Vaccine Immunol. 2012;19(11):1806-9. PMID 22971779.6.
Auwaerter PG, Melia MT. “Bullying Borrelia: When the Culture of Science is Under Attack.” Trans Am Clin Climatol Assoc. 2012;123:79-90. PMID 23303970.
Melia MT, Muir AJ, McCone J, Shiffman ML, King JW, Herrine SK, Galler GW, Bloomer JR, Nunes FA, Brown KA, Mullen KD, Ravendhran N, Ghalib RH, Boparai N, Jiang R, Noviello S, Brass CA, Albrecht JK, McHutchison JG, Sulkowski MS. “Racial Differences in Hepatitis C Treatment Eligibility.” Hepatology. 2011;54(1):70-78. PMID 21488082.4.
Melia M, O''Neill S, Calderon S, Hewitt S, Orlando K, Bithell-Taylor K, Affeln D, Conti C, Wright SB. “Development of a Flexible, Computerized Database to Prioritize, Record, and Report Influenza Vaccination Rates for Health Care Personnel.” Infect Control Hosp Epidemiol 2009;30(4):361-9.3.
Oz M, Melia MT, Soldatov NM, Abernethy DR, Morad M. Functional coupling of human L-type Ca2+ channel and angiotensin AT1A receptor co-expressed in Xenopus laevis oocytes: Involvement of the carboxyl-terminal Ca2+ sensors. Molecular Pharmacology. 1998;54(6):1106-1112.
Piggott D, Higgins Y, Melia MT, Ellis B, Carroll K, McFarland E, Auwaerter P. “Propionibacterium acnes Prosthetic Joint Infections 2000-2012: Potential Role of Nonoperative Management.” IDWeek 2013, San Francisco, California.
Melia M, Bru N, Poordad F, Lawitz EJ, Shiffman ML, McHutchison JG, Muir AJ, Galler GW, McCone J, Nyberg LM, Lee WM, Ghalib R, Schiff E, Long J, Noviello S, Brass CA, Pedicone LD, Albrecht JK, Sulkowski MS. “Infections during Peginterferon (PegIFN)/Ribavirin (RBV) Therapy are Associated with the Magnitude of Decline in the Total Lymphocyte Count: Results of the IDEAL Study.” The 46th Annual Meeting of the European Association for the Study of the Liver, 2011, Berlin, Germany.
Barclay SS, Melia MT, Auwaerter PG. “Misdiagnosis of Late Lyme Arthritis by Synovial Fluid Borrelia burgdorferi Western Blot Testing.” The 48th Annual Meeting of the Infectious Diseases Society of America, 2010, Vancouver, BC, Canada.
Melia MT, Mehta SH, Sutcliffe C, Moore RD, Thomas DL, Sulkowski MS. “Risk Factors for Incident Thrombocytopenia Among HIV-Infected Persons During the HAART Era: The Impact of Hepatitis C.” The 48th Annual Meeting of the Infectious Diseases Society of America, 2010, Vancouver, BC, Canada.
Melia MT, Jablkowski M, Pulkstenis E, Subramanian M, Sulkowski MS. “Risk Factors for Incident Infections During Hepatitis C Treatment.” The 48th Annual Meeting of the Infectious Diseases Society of America, 2010, Vancouver, BC, Canada.
Melia MT, Muir AJ, McCone J, Shiffman ML, King J, Herrine SK, Galler GW, Bloomer J, Nunes FA, Brown KA, Mullen KD, Ravendhran N, Cassidy W, Ghalib R, Boparai N, Jiang R, Noviello S, Brass CA, Albrecht JK, McHutchison JG, Sulkowski MS. Analysis of Reasons for Treatment Ineligibility in the IDEAL Study: African Americans (AAs) vs. Non-African Americans (Non-AAs). The 60th Annual Meeting of the American Association for the Study of Liver Diseases, 2009, Boston, MA.
Melia MT, Karginova EA, Abernethy DR, Morad M, Soldatov NM. Stimuli- and age-dependent expression of Ca2+ channel α1C subunit splice variant with exon 21 contributing to lower dihydropyridine sensitivity. The 43rd Annual Meeting of the Society for Biophysics, Baltimore. Biophysical Journal 1999;76:A396.
Oz M, Soldatov NM, Melia MT, Sandberg K, Abernethy DR, Morad M. Inhibition of recombinant human L-type Ca2+ channel by the activation of angiotensin AT1A receptors co-expressed in Xenopus oocytes. The 42nd Annual Meeting of the Society for Biophysics, Kansas City. Biophysical Journal 1998;74:A378.
Soldatov NM, Oz M, Melia MT, Abernethy DR, Morad M. Co-expression of recombinant human L-type Ca2+ channel and angiotensin AT1A receptor in Xenopus oocytes. The American Society for Pharmacology and Experimental Therapeutics 98 Meeting, San Francisco. FASEB Journal 1998;12(5):A917.